Orphazyme

ORPHA.CO

Tags: DK Healthcare Biotechnology

Orphazyme A/S Price (ORPHA.CO)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

35,312,000

(0.1219)%

Market Cap of Orphazyme (ORPHA.CO)

Market cap:

As of , ORPHA.CO has a market cap of . This makes ORPHA.CO the 143th most valuable company in the DK by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $407.0-1525.0
Market Cap 46.72M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Jakob Færch Bendtsen
IPO Date: November, 21, 2017
Country: DK
Currency: DKK
Headquaters: No Data
Employees: 1

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: